Ann Parke, MBBS; Donald Maier, MD; Daniel Wilson, BA; John Andreoli, MD; Mark Ballow, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: In their letter ( 1 ) on the use of intravenous immunoglobulin therapy (IVIG) in pregnant women with antiphospholipid antibodies and a history of fetal loss, Francois and colleagues suggest that IVIG may be the safest therapy to use in such women. From our experience with a young woman with the primary antiphospholipid antibody syndrome, we agree with their recommendation.
In a 29-year-old white woman who previously had five spontaneous abortions, a full gynecologic examination failed to show any cause for her recurrent abortions. Tests for autoantibodies, including antiphospholipid (APL) antibodies, indicated the presence of numerous autoantibodies,
Parke A, Maier D, Wilson D, et al. Intravenous Gamma-Globulin, Antiphospholipid Antibodies, and Pregnancy. Ann Intern Med. 1989;110:495–496. doi: https://doi.org/10.7326/0003-4819-110-6-495_2
Download citation file:
Published: Ann Intern Med. 1989;110(6):495-496.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use